Title: BALANCING CONSERVATION OBJECTIVES AND METHODS FOR AnGR: THE EMERGING ROLE OF EX SITU IN VITRO CONSER
1BALANCING CONSERVATION OBJECTIVES AND METHODS FOR
AnGRTHE EMERGING ROLE OF EX SITU IN VITRO
CONSERVATION
- Sipke J. Hiemstra Henri Woelders
- Balice, 1 June 2007
-
2In this paper
- The need for AnGR conservation strategies
- Conservation objectives and approaches
- State of the art in cryopreservation and
reproductive technologies - Decision making for ex situ in vitro strategies
- European and global issues
3Global status and trends what is the problem ?
- Some examples
- FAO (2007) 36 of breeds in Europe and Caucasus
are categorized at risk(but what does this
mean exactly?) - Poultry, pig (and cattle) breeding industry only
a few global players left - Within-breed diversity often limited, e.g.
Holstein Friesian Effective population size lt
100 - Agro-ecosystems and associated local breeds
threatened - Tisdell (2003) major socio-economic causes to
loss of AnGR diversity - Economic globalisation and extension of markets
(breeding material) - Decoupling of animal husbandry from surrounding
natural environment - Increasing major threats to AnGR (e.g. Gibson et
al. 2006)
4What to conserve ?
- Breeds ?
- Allelic diversity ?
- Knowledge ?
- Ecosystems, rural areas or livelihoods ?
5In situ or ex situ how to conserve genetic
diversity
- In situ conservation
- Conservation by utilization and sustainable
breeding - Maintaining a breed in a dynamic state,
characterized by slow and balanced adaptation to
conditions and changing functions - But threatened by genetic drift, high selection
pressure, inbreeding or extinction risks
(diseases/disasters) - Ex situ conservation
- Live (in vivo) - limited scale- will not
guarantee maintenance of present day diversity-
often not a clear distinction with in situ - Cryo storage (in vitro/gene banks)- instrumental
for in situ efforts, supporting breeding today
(increase Ne)- long term objectives for rare
breeds ánd commercial breeds (insurance
market/production system changes/ calamities) - In situ and ex situ are complementary Risk
management! Long term ánd short term
objectives!
6Types of genetic resource material in gene bank?
- Spermatozoa
- Oocytes
- Embryos/embryonic cells
- Somatic cells
- Feasible?
- Practical?
- Economical?
7Cryobiologic principles
- Cryopreservation suspended animation in liquid
nitrogen (-196 C) - All chemical and physical processes arrested
- Only Cosmic background radiation is a possible
source of DNA damage. - This is estimated to become relevant only after
several thousands of years (Mazur, 1985) - Consequently Storage is safe for several
thousands of years, possibly longer
8Semen cryopreservation
- Semen of most species can be frozen adequately
- Fair post-thaw viability can be expected for most
species - Dedicated freezing media and equipment available
- Optimal freezing media, cryoprotectant,
protocols, widely varies between species (i.e.
mammals and birds) - Large differences between species in
insemination techniques and pregnancy rates
using fresh or frozen semen - Fertility of frozen semen lower than that of
fresh semen - In cattle, pregnancy rates with frozen semen are
as good as that of fresh semen, but specific
problems in other species
9Example improving freezing boar semen
- optimising cooling rate
- minimising cryo-damage
- less boar variation with new method
- elevation of level of poorest males
Woelders et al., 2005
10Example progress in cock semen preservation
- State of the art often low post-thaw survival
and fertilized eggs - Recent research
- A large number of cryoprotective agents (CPAs)
have been tested (glycerol, DMSO, EG, DMA) - A number of media have been compared
- A new medium was composed that combines the
advantages of different media - The interaction between cooling rate and CPA
concentration was studied - Good results with high cooling rate and DMA
11 Dev embr. Underdev embryos
Dev. embryos Underdeveloped embryos
12Semen cryopreservation (dis)advantages
- Advantages
- Existing infrastructure for semen collection
and for insemination in a number of species - Sperm survival after thawing is adequate for most
species - But freezability varies among species,
breeds/lines and males - Disadvantages
- Back-crossing is required, at least for 6
generations - High re-generation costs (higher than embryos)
- Mitochondrial genes are not conserved
- In some species or countries no infrastructure
is available or collection may be a problem
13Cryopreservation of oocytes
- Considerable progress with oocyte
cryopreservation in last 10 years - Viable oocytes after freezing and thawing in
great number of species - But.. chance of getting healthy offspring from
cryopreserved oocytes is still much lower
compared to embryos - In vitro production of embryos is possible for
major livestock species, but efficiency varies
between species(collection of oocytes from
slaughtered animals or by the use of ovum
pick-up) - Freezing oocytes of avian and fish species is not
successful (large size, high lipid content, polar
organisation)
OPS vitrified horse COC Tharasanit et al.
14Oocytes ánd semen (dis)advantages
- Full complement of chromosomal and mitochondrial
genes - Flexibility in combining oocytes and semen
- Overall costs of ovum pick-up and IVF probably
higher than using embryos - Efficiency and reliability of using oocytes for
generating embryos and young is still much lower
compared to cryopreserved embryos
15Cryopreservation of embryos/embryonic cells
- Cryopreservation of embryos is adequate for
mammalian livestock species (highly successful in
cattle, recent good results in pigs) - Success dependent on stage of the embryo (good
results with blastocysts) - Not successful in birds and fish (large size,
high lipid content, polar organisation of early
embryo) - Surgical ET possible in all mammalian livestock
species - Non-surgical ET possible in cattle, horses (and
pig)
16Embryo cryopreservation (dis)advantages
- Full complement of chromosomal and mitochondrial
genes - In some species infrastructure for ET is
available (cattle), developing (pig) and is
possible in other species - Costs of embryo collection and freezing is in
general much higher than semen cryopreservation - No backcrossing needed low re-generation costs
- Especially interesting for species with long
generation intervals and low reproductive rates
17Cryopreservation of somatic cells
- Collection of suitable somatic cells is possible,
easy and cheap ! - Different cell types, e.g. skin fibroblasts, can
be readily cryopreserved - Using relatively simple cryopreservation
techniques - Use of somatic cells to generate offspring
requires reproductive cloning
18Somatic cells an alternative for semen/embryos?
- In mammals, live offspring reported in sheep,
cattle, mice, pigs, goats, horses, rabbits and
cats - No successful cloning reported in poultry
- Full complement of chromosomal, but no
mitochondrial genes, after transfer of nuclei - Low up-front costs of freezing somatic cells
- Reproductive cloning not efficient and not safe
(yet)(lt4 transferred embryos develop into
viable offspring)(abortions and malformed young) - Ethical issues (but also clear differences in
societal discussion between e.g. EU and USA) - Future developments on longer term are likely
19Emerging reproductive technologies
- Transplantation of ovarian tissue and germ cells
- Successful germ cell transplantation in mammals,
poultry and fish - These emerging technologies may enable production
of gametes or offspring of rare or extinct breeds
by abundantly available individuals of related
common breeds
20Costs of cryopreservation
- Limited published information on costs of AnGR
conservation - Investments today (collection, freezing) versus
future regeneration/use costs - Long term storage costs relatively cheap
(compared to in situ) - Technical developments further cost reduction
expected - Less collections/ejaculates needed
- Less doses needed for re-generation
- i.e. extraction of semen from the epididymus
(after slaughter/castration) - Boetcher/Gandini combination of embryos and
semen is cost-effective
21In summary
22Choosing the technique (GandiniOldenbroek, 2007)
- Steps
- Which conservation objectives apply ?
- Rank techniques for their efficacy to reach the
objectives - Rank techniques for risk of failure
- Rank techniques for costs
- Choose the technique
23Choosing the donors (sampling)
- Decision-making at two levels
- Breeds to be included (prioritization of breeds)
- Sampling of individuals within selected breeds
-
24Prioritising breeds from a genetic point of view
Total genetic diversity of a group of breeds
Contribution of a single breed to the total
diversity of the group of breeds
- contribution to the between-breed diversity
- contribution to the within-breed diversity
Centre for Genetic Resources, The Netherlands
25Poultry
- Estimation of Marker
- Estimated Kinships
26Sampling, not only technical/genetic
considerations..
- Interest of stakeholders
- Funding limitations
- Research costs lt-gt sampling-inefficiency costs?
- Cultural, historical reasons
- Legal issues/ownership
- Infrastructure and existing capacity
- Sanitary/veterinary aspects
- Quality standards
27Emerging role for ex situ (long term short
term) ?
- Long term in situ is often more expensive than ex
situ in vitro - In situ is vulnerable to serious threats
- Diseases and disasters
- Genetic risks (drift, strong selection, etc)
- Age of current farmers
- Etc.
- We can not control decisions of farmers,
breeders and other stakeholders (unpredictable
future) - Fast technological (omics) developments will
trigger/change conservation and future use
(exploitation) - Developments/genetic erosion go very fast better
be quick, especially for species with short
generation interval
28International issues
- Local versus regional transboundary versus
international transboundary ? breed specific
(cross-border) strategies needed - Detailed assessment of current status and roles
of ex situ conservation by country/species/breeds - National sovereignty but need for regional (and
global) collaboration and arrangements/support - Mechanism to be developed to involve wider group
of stakeholders (financially, national and
international) - Technical/research cooperation
- Regional (or global) gene bank?
- Rights and ownership?
- Rationalization/optimization of gene bank
collections !
29Thank you for your attention